3 results match your criteria: "RUHS College of Medical Sciences and Government RDBP Jaipuria Hospital[Affiliation]"

Belimumab in Systemic Lupus Erythematosus.

Indian J Dermatol

October 2016

Department of Skin and VD, RUHS College of Medical Sciences and Government RDBP Jaipuria Hospital, Jaipur, Rajasthan, India.

Belimumab is the only approved biological agent for the treatment of systemic lupus erythematosus (SLE). It is a fully humanized IgG1γ monoclonal antibody directed against soluble B lymphocyte stimulator (BLyS). It is indicated as an add-on therapy for the treatment of adult patients with active, autoantibody-positive SLE, who are receiving standard therapy.

View Article and Find Full Text PDF